Form 4: Health Catalyst Chief Commercial Officer Disposes of Shares for Tax Obligations

Health Catalyst, Inc.'s Chief Commercial Officer, Kevin Lee Freeman, reported the disposition of 4,747 shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• Kevin Lee Freeman, Chief Commercial Officer of Health Catalyst, Inc. (HCAT), filed a Form 4 with the SEC.
• The filing reports a transaction on June 2, 2025, involving the disposition of 4,747 shares of HCAT common stock.
• The shares were sold at a price of $3.6348 per share.
• This sale was a 'sell to cover' transaction, mandated by the Issuer's equity incentive plans to satisfy tax withholding obligations upon the vesting of Restricted Stock Units.
• The transaction was not a discretionary trade by the reporting person.
• Following this transaction, Kevin Lee Freeman beneficially owns 379,665 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-discretionary 'sell to cover' for tax purposes, which is a standard practice for equity compensation vesting and does not indicate a change in management's view of the company's prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units.
• This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a 'sell to cover' transaction and does not represent a discretionary trade by the Reporting Person.

Industry Context

This SEC Form 4 filing details an individual insider transaction, specifically a 'sell to cover' for tax purposes, which is a routine event for executives receiving equity compensation. It does not provide information related to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The disposition of shares is a routine tax-related event and is unlikely to have a significant impact on existing shareholders, as it is not a discretionary sale indicating a lack of confidence.

Key Dates

Keywords

Health Catalyst, HCAT, SEC Form 4, Insider Transaction, Restricted Stock Units, Tax Withholding, Equity Incentive Plans, Chief Commercial Officer